Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 28, 2021; 27(28): 4536-4554
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4536
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4536
Main indications for the laparo-endoscopic RV | RV preferable vs laparoscopic CBD exploration | RV preferable vs sequential ERCP-ES |
(1) CBD stones not easily extractable | (A) Need of higher surgical skill | (a) Risk of synchronization |
through the cystic duct | (B) Longer operation time | (b) Risk of unnecessary ERCP |
Positive factor - > (time reduction) | (C) Need of biliary drain | (c) Risk of difficult retrograde |
cannulation | ||
(2) Multiple small CBD stones and large friable stones | A, B, C + | a, b, c |
Positive factor - > (reduction of risk of recurrence) | (D) High risk of residual fragments and recurrence | |
(3) Any type of CBD stones with delayed passage of the | A, B, C, D + | a, b, c |
contrast medium during IOC or T-tube-IOC after | (E) High risk of undertreatment of chronic | |
laparoscopic CBD exploration | papillitis and of maintenance of underlying causes | |
Positive factor - > (reduction of risk of recurrence) | ||
(4) CBD stones with previous cholangitis | A, B, C, D + | a, b, c + |
Positive factor - > (reduction of risk of recurrence) | (E) High risk of maintenance of underlying causes | (d) Avoidance of contrast medium injection |
at the papilla | with risk of recurrence of cholangitis | |
(5) CBD stones after recurrent acute biliary pancreatitis | A, B, C, D, E | a, b, c, d + |
or hyperbilirubinemia | (e) risk of recurrence of ERCP | |
Positive factor - > (iatrogenic risk reduction) | related acute pancreatitis | |
(6) Known or unsuspected sphincter of Oddi dysfunction, | A, B, C, D, E | a, b, c, d, e |
cholecysto-lithiasis with or without CBD stones | ||
Positive factor - > (iatrogenic risk reduction) | ||
(7) CBD stones and/or abovementioned problems in patients | A, B, C, D, E + | a, b, c, d, e + |
with Billroth Ⅱ during open cholecystectomy | (F) Manual drive of the endoscope by the surgeon | (f) more difficult ERCP |
Positive factor - > (iatrogenic risk reduction) | in the afferent jejunal loop | |
(8) CBD stones, SOD, acute pancreatitis in children/CBD | A, B, C, D, E + | a, b, c, d, e, f + |
stones in patients with normal or thin CBD | (G) difficult laparoscopic CBD exploration and risk | (h) avoidance of |
Positive factor -> (iatrogenic risk reduction) | of stenosis of the suture | sphincterotomy in children |
(9) CBD stones and/or SOD after failure of preoperative | A, B, C, D, E | a, b, c, d, e, f |
ERCP-ES or recurrence of acute biliary pancreatitis | ||
Positive factor - > (iatrogenic risk reduction) | ||
(10) Inexperienced surgeon for laparoscopic CBD exploration | A, B, C, D, E, G | a, b, c, d, e, f |
Positive factor - > (iatrogenic risk reduction) |
- Citation: Cianci P, Restini E. Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches. World J Gastroenterol 2021; 27(28): 4536-4554
- URL: https://www.wjgnet.com/1007-9327/full/v27/i28/4536.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i28.4536